S. Markabi
Impact in
- Neurology top 10%
- Neurological Disorders and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Traumatic Brain Injury and Neurovascular Disturbances
- Psychiatry and Mental health top 10%
- Attention Deficit Hyperactivity Disorder
- Epilepsy research and treatment
Papers in
-
- Epilepsy research and treatment 2
- Attention Deficit Hyperactivity Disorder 1
-
- Retinal Diseases and Treatments 2
- Co-authors
- Goeril Karlsson (3 shared papers)Stephen M. Davis (1 shared paper)John W. Norris (1 shared paper)Kennedy R. Lees (1 shared paper)Gregory W. Albers (1 shared paper)Hans‐Christoph Diener (1 shared paper)Vincent Caillard (1 shared paper)Declan Quinn (1 shared paper)
- Journals
- Electroencephalography and Clinical Neurophysiology (2 papers)The Journal of Clinical Pharmacology (1 paper)Stroke (1 paper)Pediatric Drugs (1 paper)Journal of Neural Transmission (1 paper)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
S. Markabi
10 papers receiving 511 citations
Peers
Comparison fields: 5 of 62
- Neurology 82
- Psychiatry and Mental health 124
- Ophthalmology 54
- Epidemiology 155
- Cellular and Molecular Neuroscience 63
Countries citing papers authored by S. Markabi
This map shows the geographic impact of S. Markabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Markabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Markabi more than expected).
Fields of papers citing papers by S. Markabi
This network shows the impact of papers produced by S. Markabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Markabi. The network helps show where S. Markabi may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Markabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 282 | |
| 2 | 2003 | 86 | |
| 3 | 2010 | 58 | |
| 4 | 1999 | 39 | |
| 5 | 2004 | 35 | |
| 6 | 2004 | 27 | |
| 7 | 1990 | 13 | |
| 8 | 1990 | 9 | |
| 9 | [Controlled study of treatment of residual depression by clomipramine versus placebo]. | 1994 | 3 |
| 10 | 1997 | 2 | |
| 11 | 2009 | 1 |
About S. Markabi
S. Markabi is a scholar working on Psychiatry and Mental health, Ophthalmology, Neurology, Epidemiology and Neurology, having authored 11 papers that have together received 555 indexed citations. Recurring topics across this work include Epilepsy research and treatment (2 papers), Acute Ischemic Stroke Management (2 papers), Retinal Diseases and Treatments (2 papers), Hemispheric Asymmetry in Neuroscience (1 paper), Attention Deficit Hyperactivity Disorder (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Neurological Disorders and Treatments (1 paper) and Treatment of Major Depression (1 paper). The work is most often cited by research in Neurology (82 citations), Psychiatry and Mental health (124 citations), Ophthalmology (54 citations), Epidemiology (155 citations) and Cellular and Molecular Neuroscience (63 citations). S. Markabi has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Goeril Karlsson, Stephen M. Davis, John W. Norris, Kennedy R. Lees, Gregory W. Albers, Hans‐Christoph Diener, Vincent Caillard, Declan Quinn, Meredith A. Weidenman and Harald Pohlmann. Their work appears in journals such as Electroencephalography and Clinical Neurophysiology, The Journal of Clinical Pharmacology, Stroke, Pediatric Drugs and Journal of Neural Transmission.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.